Rest-Up: brief programs to reduce heavy drinking and cannabis use and improve sleep in young adults

Efficacy of Brief Interventions to Reduce Comorbid Alcohol and Cannabis Misuse and Sleep Impairment in Young Adults (Rest-Up RCT)

Not applicable Interventional University of Washington · NCT06736444

This program will test short, integrated behavioral sessions to reduce heavy drinking and cannabis use and improve sleep in 18–29-year-olds with sleep problems who live in Washington State.

Quick facts

PhaseNot applicable
Study typeInterventional
Enrollment800 (estimated)
Ages18 Years to 29 Years
SexAll
SponsorUniversity of Washington Academic / other
Locations1 site (Seattle, Washington)
Trial IDNCT06736444 on ClinicalTrials.gov

What this trial studies

This randomized interventional study enrolls young adults with insomnia, recent heavy episodic drinking, and regular cannabis use to receive a brief integrated intervention or an attention-control condition. The active intervention combines Brief Behavioral Therapy for Insomnia (BBTI) with the Brief Alcohol Screening and Intervention for College Students (BASICS) to target sleep, alcohol, and cannabis use together. Outcomes include changes in alcohol and cannabis use and related consequences, plus sleep severity and daytime functioning, measured over follow-up. Recruitment is limited to residents of Washington State and sessions are delivered through the University of Washington research program.

Who should consider this trial

Good fit: Ideal candidates are 18–29-year-olds who live in Washington State, have at least moderate insomnia (ISI ≥10), report recent heavy episodic drinking as defined by the protocol, and have used cannabis four or more times in the past month.

Not a fit: People outside the age or residency requirements, those without sleep impairment or without recent heavy drinking or cannabis use, and individuals with more severe substance use disorders needing specialized care may not receive benefit from this brief intervention.

Why it matters

Potential benefit: If successful, this brief combined approach could help young adults reduce heavy drinking and cannabis use and improve sleep using short, scalable sessions.

How similar studies have performed: Components of this approach have prior support—BBTI improves insomnia and BASICS reduces college drinking—but using them together to treat co-occurring alcohol, cannabis, and sleep problems is relatively novel.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Participants must: 1) be 18-29 years old; 2) reside in Washington State; 3) have valid email address; 4) score on the Insomnia Severity Index (ISI) of 10 or higher, indicating at least a moderate score (score of 2 or more) on one or more of the first three items of the ISI measuring difficulty falling asleep, staying asleep, or waking up too early; 5a) report at least two heavy drinking episodes (4+ drinks for women /gender diverse, 5+ for men in a 2-hour period) in the past month; or 5b) 1 heavy drinking occasion and at least 4 total drinking occasions in the past month; 6) have used cannabis 4+ times in the past month; and 7) did not participate in the R34 pilot feasibility trial on which the current RCT is based.

Exclusion Criteria:

* Participants that don't meet inclusion criteria and/or failure to consent to further participation.

Where this trial is running

Seattle, Washington

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions InsomniaAlcohol UseMarijuana UseYoung Adults
Last reviewed 2026-06-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.